Acurx pharmaceuticals, inc. to discuss second quarter 2024 financial results on august 9, 2024 conference call and provide business update

Staten island, n.y. , july 16, 2024 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company will discuss its second quarter 2024 financial results on friday, august 9, 2024 at 8:00 am et before the u.s. financial markets open.
ACXP Ratings Summary
ACXP Quant Ranking